References
- Becker, K. G. 2001. The common genetic hypothesis of autoimmune/inflammatory disease. Curr. Opin. Allergy Clin. Immunol. 1: 399–405
- Ytterberg, S. R., and T. J. Schnitzer. 1982. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 25: 401–406
- Hooks, J. J., H. M. Moutsopoulos, S. A. Geis, et al. 1979. Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301: 5–8
- Baechler, E. C., F. M. Batliwalla, G. Karypis, et al. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A 100: 2610–2615
- Baechler, E. C., F. M. Batliwalla, A. M. Reed, et al. 2006. Gene expression profiling in human autoimmunity. Immunol. Rev. 210: 120–137
- Delgado-Vega, A. M., M. E. Alarcon-Riquelme, and S. V. Kozyrev. 2010. Genetic associations in type I interferon related pathways with autoimmunity. Arthritis Res. Ther. 12: S2
- Liu, Y., A. A. Jesus, B. Marrero, et al. 2014. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 371: 507–518
- Jeremiah, N., B. Neven, M. Gentili, et al. 2014. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J. Clin. Invest. 124: 5516–5520
- Hochberg, M. C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40: 1725
- Miyakis, S., M. D. Lockshin, T. Atsumi, et al. 2006. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4: 295–306
- LeRoy, E. C., C. Black, R. Fleischmajer, et al. 1988. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15: 202–205
- Bohan, A., and J. B. Peter. 1975. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292: 344–347
- Bohan, A., and J. B. Peter. 1975. Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med. 292: 403–407
- Hunder, G. G., D. A. Bloch, B. A. Michel, et al. 1990. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 33: 1122–1128
- Leavitt, R. Y., A. S. Fauci, D. A. Bloch, et al. 1990. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 33: 1101–1107
- Masi, A. T., G. G. Hunder, J. T. Lie, et al. 1990. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 33: 1094–1100
- Vollmann, J., and R. Winau. 1996. Informed consent in human experimentation before the Nuremberg code. BMJ 313: 1445–1449
- Ishikawa, H., and G. N. Barber. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455: 674–678
- Burdette, D. L., K. M. Monroe, K. Sotelo-Troha, et al. 2011. STING is a direct innate immune sensor of cyclic di-GMP. Nature 478: 515–518
- Ahn, J., D. Gutman, S. Saijo, and G. N. Barber. 2012. STING manifests self DNA-dependent inflammatory disease. Proc. Natl. Acad. Sci. U. S. A 109: 19386–19391
- Labrador-Horrillo, M., M. A. Martinez, A. Selva-O'Callaghan, et al. 2014. Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis. J. Immunol. Res. 2014: 290797
- Narang, N. S., L. Casciola-Rosen, S. Li, et al. 2015. Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease. Arthritis Care Res. 67: 667–672
- Unterholzner, L. 2013. The interferon response to intracellular DNA: why so many receptors? Immunobiology 218: 1312–1321
- Rice, G. I., Y. del Toro Duany, E. M. Jenkinson, et al. 2014. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat. Genet. 46: 503–509
- Cen, H., W. Wang, R. X. Leng, et al. 2013. Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Autoimmunity 46: 455–462
- Zouk, H., L. Marchand, Q. Li, and C. Polychronakos. 2014. Functional characterization of the Thr946Ala SNP at the type 1 diabetes IFIH1 locus. Autoimmunity 47: 40–45